Posted on Friday, 12 February 2010 by
Maureen Martino
When Pfizer refocused its ops in November, it left about 600 of its 1,000 employees in the St. Louis area without a job. But St. Louis University doesn't want to see that talent go to waste. Some of those scientists may find a home at the school, which announced that it's launching a new research center focused on discovering treatments for illnesses that affect the developing world.
Read the full article at FierceBiotech